Executive Service Agreement Amendment, dated as of April 6, 2022 by and between F-star Therapeutics Ltd and Eliot Forster, Ph.D

Contract Categories: Business Operations - Services Agreements
EX-10.1 2 fstx-ex10_1.htm EX-10.1 EX-10.1

 

Exhibit 10.1

 

 

Tel: +44 (0)1223 497400

Fax: +44 (0)1223 497461

***@***

 

F-star Therapeutics Limited

Eddeva B920

Babraham Research Campus

Cambridge

CB22 3AT

United Kingdom

 

www.f-star.com

 

STRICTLY PRIVATE & CONFIDENTIAL

Eliot Forster

Addresses

 

6 April 2022

 

 

Dear Eliot

 

Amendment to Service Agreement

 

 

I am writing to confirm an Amendment to your Service Agreement with effect from 31 March 2022.

The parties hereby agree as follows:

1.
Section 18.6 of the Service Agreement is amended by deleting the reference to, “to the extent not assumed by an acquirer”.
2.
Except as specifically modified herein, any of the other terms of the Agreement shall remain in full force and effect.

 

 

In witness whereof, the parties hereto have executed the Amendment as of the date first written above.

 

 

 

For F-star Therapeutics Ltd

 

For Employee

 

Signature:

/s/ Darlene Deptula-Hicks

 

 

Signature:

 

/s/ Eliot R. Forster

Name:

Darlene Deptula-Hicks

 

Name:

Eliot Forster

Title:

Chief Financial Officer

 

Title:

Chief Executive Officer

 

 

 

 

F-star Therapeutics Limited

Eddeva B920 | Babraham Research Campus | Cambridge, CB22 3AT, UK | T: +44 1223 497400 | www.f-star.com